Valladales-Restrepo, Luis Fernando http://orcid.org/0000-0002-4245-0101
Ospina-Cano, Juan Alberto
Aristizábal-Carmona, Brayan Stiven http://orcid.org/0000-0002-4105-4510
Machado-Alba, Jorge Enrique http://orcid.org/0000-0002-8455-0936
Article History
Accepted: 22 August 2024
First Online: 7 September 2024
Declarations
:
: The present study did not receive funding.
: Jorge Enrique Machado-Alba is an Editorial Board member of Drugs—Real World Outcomes. Jorge Enrique Machado-Alba was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Luis Fernando Valladales-Restrepo, Juan Alberto Ospina-Cano and Brayan Stiven Aristizábal-Carmona declare no conflicts of interest.
: The protocol was endorsed by the Bioethics Committee of the Technological University of Pereira in the category of ‘research without risk’ (approval code: CBE.48-280621). The principles of confidentiality of information established by the Declaration of Helsinki were respected.
: Not applicable; this is a retrospective observational study.
: The manuscript was translated to English by American Journal Experts.
: Protocols.io. In the repository you will find the anonymized database of all the variables of the patients included in the study.
: .
: LFVR: conceptualization, methodology, formal analysis, investigation, data curation and writing the original draft. JAOC: formal analysis, investigation, data curation. BSAC: formal analysis, investigation, data curation; JEMA: methodology, validation, formal analysis, resources, writing, review and editing and supervision. All authors read and approved the final version.